상세정보
- |Home >
- 상세정보
부가기능
MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?: Several new drugs for multiple sclerosis could launch within the next two years, but amid escalating drug costs, payors are taking a harder look at the therapeutic category. These drugs will face increasing reimbursement hurdles, as payors implement the first prior authorization and step therapy protocols and look for ways to implement further cost reductions
기사 상세정보
소장정보
- 소장정보
| No. | 권호·제본정보 보기 | 소장처 | 소장사항 | 청구기호 | 구독 | 최근입수호 |
|---|---|---|---|---|---|---|
| 1 | 중앙도서관/3층 외국학술지지원센터/ | 610 I35 | 구독중단 | v.34 no.11 |
하단메뉴
